NUR 372 EXAM 2 MEDICATIONS Flashcards

1
Q

CLASS: ALBUTEROL

A
  • beta2-adrenergic agonist
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

THERAPEUTIC USE: ALBUTEROL

A
  • long-term management of asthma
  • prevention of exercise-induced asthma
  • treatment of ongoing asthma exacerbations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

SIDE/ADVERSE EFFECTS: ALBUTEROL

A
  • tachycardia
  • heart palpitations
  • angina
  • tremors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

NURSING INTERVENTIONS: ALBUTEROL

A
  • monitor and report tachycardia, heart palpitations, and chest pain
  • monitor and report tremors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

PATIENT INSTRUCTIONS: ALBUTEROL

A
  • report chest pain and palpitations
  • report increase in pulse rate
  • avoid caffeine
  • notify provider if tremors interfere with ADLs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MECHANISM OF ACTION: ALBUTEROL

A
  • acts by selectively activating the beta2-receptors in the bronchial smooth muscle, resulting in bronchodilation and decreased airway resistance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CLASS: FUROSEMIDE

A
  • loop diuretic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

THERAPEUTIC USE: FUROSEMIDE

A
  • treats pulmonary edema in heart failure
  • treats edema caused by renal, hepatic or cardiac failure not affected by other diuretics
  • treats hypertension not controlled by other diuretics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ADVERSE EFFECTS: FUROSEMIDE

A
  • hypotension
  • electrolyte imbalance (hyponatremia, hypochloremia, dehydration, hypokalemia)
  • ototoxicity
  • hyperglycemia
  • increased uric acid levels with gouty arthritis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

NURSING INTERVENTIONS: FUROSEMIDE

A
  • monitor serum electrolyte levels; notify provider of abnormal levels
  • monitor for signs of electrolyte imbalance
  • if hypokalemia occurs, monitor for cardiac dysdysrhythmias
  • if hypokalemia is a risk, furosemide can be combined with a potassium-sparing diuretic
  • monitor blood glucose
  • ensure patient does not take other ototoxic drugs
  • monitor for hearing loss, tinnitus, vertigo
  • monitor uric acid levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

PATIENT INSTRUCTIONS: FUROSEMIDE

A
  • eat foods rich in potassium
  • report signs of electrolyte imbalance: confusion, muscle twitching, weakness, nausea
  • teach patient to have BP monitored
  • report dizziness, syncope
  • report new onset of hearing loss, ringing in ears, or vertigo
  • carefully monitor blood glucose
  • patients who have history of gout need to report symptom onset to provider
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MECHANISM OF ACTION: FUROSEMIDE

A
  • inhibit reabsorption of Na+ and Cl- in ascending limb of the loop of Henle to prevent reabsorption of water
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

CLASS: BISACODYL

A
  • stimulant laxatives
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

THERAPEUTIC USES: BISACODYL

A
  • constipation from opioid use or from slow intestinal transit
  • colon evacuation prior to elective procedures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ADVERSE EFFECTS: BISACODYL

A
  • diarrhea
  • abdominal cramps
  • burning sensation (suppositories)
  • prostates (prolonged use)
  • laxative abuse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

NURSING INTERVENTIONS: BISACODYL

A
  • monitor for severe diarrhea and dehydration
  • tell patients to expect rectal/anal burning
  • monitor for rectal discomfort, bleeding, or discharge of mucus or pus
  • discourage long-term use
  • monitor I&O
  • monitor BM pattern
17
Q

PATIENT INSTRUCTIONS: BISACODYL

A
  • report severe diarrhea and stop taking drugs
  • drink fluids
  • expect burning sensation with suppository use
  • report rectal discomfort, bleeding, or discharge
  • do not use repeatedly or for extended periods
  • increase in fluid intake and add high-fiber foods slowly
18
Q

MECHANISM OF ACTION: BISACODYL

A
  • stimulation of intestinal peristalsis
19
Q

CLASS: COLACE

A
  • stool softener
20
Q

THERAPEUTIC USE: COLACE

A
  • constipation

- prevention of fecal impaction, straining during defecation, painful elimination of hard stools

21
Q

ADVERSE EFFECTS: COLACE

A
  • diarrhea

- mild abdominal cramps

22
Q

NURSING INTERVENTIONS: COLACE

A
  • monitor for severe diarrhea and dehydration
23
Q

PATIENT INSTRUCTIONS: COLACE

A
  • report severe diarrhea and stop taking drug
  • drink fluids
  • increase exercise, fluid intake, and consume high-fiber foods
24
Q

MECHANISM OF ACTION: COLACE

A
  • lower surface tension of the stool to allow penetration of water
25
Q

CLASS: FLUTICASONE

A
  • glucocorticoid
26
Q

THERAPEUTIC USES: FLUTICASONE

A
  • long-term prophylaxis
27
Q

ADVERSE EFFECTS: FLUTICASONE

A
  • URI
  • cough
  • sinusitis
  • sinus infection
  • throat irritation
  • oral thrush
  • headache
28
Q

PATIENT TEACHING: FLUTICASONE

A
  • decrease strength of immune system and mask signs of infection
  • administer on a fixed schedule
  • oral care after administration
29
Q

MECHANISM OF ACTION: FLUTICASONE

A
  • decrease inflammation and swelling of airways, suppress mucus production, promote responsiveness of beta2-receptors
30
Q

CLASS: SPIRINOLACTONE

A
  • potassium-sparing diuretics
31
Q

THERAPEUTIC USE: SPIRINOLACTONE

A
  • hypertension
  • edema caused by HF
  • cirrhosis of the liver
  • nephrotic syndrome
  • hypokalemia
32
Q

ADVERSE EFFECTS: SPIRINOLACTONE

A
  • hyperkalemia
  • menstrual irregularities
  • abnormal hair growth
  • deepening of voice in women
  • gyenocomastia in men
33
Q

NURSING INTERVENTIONS: SPIRINOLACTONE

A
  • monitor serum potassium levels
  • monitor for cardiac dysrhythmias if hyperkalemia occurs
  • may be combined with thiazide or loop diuretic to maintain normal potassium level
  • report endocrine effects
34
Q

PATIENT INSTRUCTIONS: SPIRINOLACTONE

A
  • report palpitations, irregular pulse, or signs of hyperkalemia
  • avoid potassium supplements or large amounts of foods high in potassium and salt substitutes
  • report endocrine symptoms
35
Q

MECHANISM OF ACTION: SPIRINOLACTONE

A
  • block the effect of aldosterone on renal tubules resulting in the loss of sodium and water and retaining potassium